Yanqiao Zhang Selected Research

Drug Therapy (Chemotherapy)

5/2024	Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer.
3/2024	A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
9/2023	Retinoic Acid Signaling in Fatty Liver Disease.
1/2023	An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma.
1/2023	A Randomized Phase III Study of Anlotinib Versus Bevacizumab in Combination With CAPEOX as First-Line Therapy for RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Clinical Trial Protocol.
9/2022	An Integrated Study on the Differential Expression of the FOX Gene Family in Cancer and Their Response to Chemotherapy Drugs.
1/2022	Multiple-dose up-titration study to evaluate the pharmacokinetics, safety and antitumor activity of apatinib in advanced gastric adenocarcinoma.
1/2022	Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial.
1/2022	Comparative efficacy and toxicity of immune checkpoint inhibitors in combination with or without chemotherapy treatment for advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis.
1/2022	A multi-center effectiveness comparison study of fruquintinib with constructed external control cohort of other targeted kinase inhibitors using real-world data in third-line treatment of metastatic colorectal cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanqiao Zhang Research Topics

Disease

51	Neoplasms (Cancer) 05/2024 - 08/2013
26	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 05/2012
14	Fatty Liver 04/2024 - 02/2011
12	Inflammation (Inflammations) 11/2023 - 12/2013
12	Atherosclerosis 01/2023 - 10/2006
11	Non-alcoholic Fatty Liver Disease 10/2023 - 12/2013
11	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2011
10	Adenocarcinoma 05/2024 - 01/2011
9	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2012
8	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 03/2005
8	Carcinogenesis 01/2023 - 01/2008
7	Esophageal Squamous Cell Carcinoma 05/2024 - 01/2022
7	Colonic Neoplasms (Colon Cancer) 11/2023 - 01/2017
6	Obesity 10/2023 - 02/2012
4	Stomach Neoplasms (Stomach Cancer) 09/2023 - 01/2020
4	Lymphatic Metastasis 01/2020 - 01/2011
3	Starvation 04/2024 - 09/2004
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2016
3	Insulin Resistance 01/2021 - 01/2006
3	Hyperlipidemias (Hyperlipidemia) 04/2020 - 01/2006
2	Liver Diseases (Liver Disease) 04/2024 - 01/2018
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 01/2023
2	Disease Progression 01/2023 - 08/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 02/2017
2	Microsatellite Instability 01/2023 - 09/2014
2	Metabolic Diseases (Metabolic Disease) 01/2023 - 03/2017
2	Ovarian Neoplasms (Ovarian Cancer) 08/2021 - 01/2020
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2020 - 09/2014
2	Carcinoma (Carcinomatosis) 02/2017 - 05/2014
2	Alcoholic Fatty Liver 04/2016 - 06/2015
2	Colitis 01/2014 - 08/2013
2	Gallstones (Gallstone) 01/2008 - 10/2006
1	Pathologic Complete Response 05/2024
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 05/2024

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
11	CholesterolIBA 11/2023 - 10/2006
10	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2011
8	Messenger RNA (mRNA)IBA 11/2023 - 01/2012
8	Triglycerides (Triacylglycerol)IBA 01/2023 - 02/2011
8	MicroRNAs (MicroRNA)IBA 06/2020 - 05/2012
7	LipidsIBA 01/2023 - 01/2008
6	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2006
6	Hepatocyte Nuclear FactorsIBA 05/2022 - 02/2011
5	Immune Checkpoint InhibitorsIBA 03/2024 - 01/2021
5	Transcription Factors (Transcription Factor)IBA 01/2023 - 12/2013
5	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 06/2019
5	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 05/2012
5	Carboxylesterase (Hydrolase S)IBA 01/2021 - 01/2016
5	Bile Acids and Salts (Bile Acids)IBA 01/2021 - 01/2008
5	Gemcitabine FDA Link 01/2019 - 01/2012
4	toripalimabIBA 05/2024 - 01/2020
4	Apolipoproteins E (ApoE)IBA 11/2023 - 06/2015
4	Capecitabine (Xeloda)FDA Link 03/2023 - 01/2020
4	Therapeutic UsesIBA 09/2017 - 01/2016
4	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2017 - 01/2006
3	Indicators and Reagents (Reagents)IBA 05/2024 - 06/2019
3	Phosphotransferases (Kinase)IBA 05/2024 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 04/2016
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2023 - 10/2022
3	SirtuinsIBA 01/2023 - 08/2018
3	Cisplatin (Platino)FDA LinkGeneric 05/2022 - 05/2012
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2022 - 12/2021
3	CateninsIBA 01/2022 - 04/2014
3	apatinibIBA 01/2022 - 01/2021
3	PlatinumIBA 01/2022 - 01/2016
3	Sterol Regulatory Element Binding Protein 1IBA 01/2021 - 09/2004
3	Lipoproteins (Lipoprotein)IBA 01/2021 - 10/2006
3	FructoseIBA 01/2021 - 06/2019
3	CarbohydratesIBA 01/2019 - 09/2004
2	surufatinibIBA 05/2024 - 01/2024
2	Sunitinib (Sutent)FDA Link 11/2023 - 12/2016
2	Retinoic Acid Receptor alphaIBA 10/2023 - 10/2022
2	Tyrosine Kinase InhibitorsIBA 01/2023 - 01/2021
2	sintilimabIBA 01/2023 - 01/2022
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 05/2022
2	Activating Transcription Factor 3IBA 01/2023 - 11/2021
2	HMPL-013IBA 01/2023 - 01/2022
2	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 09/2022 - 01/2019
2	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2021
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2021
2	LuciferasesIBA 01/2022 - 01/2019
2	SterolsIBA 01/2021 - 09/2004
2	camrelizumabIBA 01/2021 - 01/2021
2	Forkhead Box Protein M1IBA 01/2019 - 02/2015
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 04/2016
2	RNA (Ribonucleic Acid)IBA 01/2018 - 01/2017
2	CytokinesIBA 09/2017 - 01/2014
2	Cyclin D1IBA 01/2011 - 07/2010
1	Succinic Acid (Succinate)IBA 04/2024
1	Acetates (Acetic Acid Esters)FDA Link 04/2024
1	Dicarboxylic AcidsIBA 04/2024
1	Cytochrome P450 Family 4IBA 04/2024
1	Cytochrome P-450 CYP4A (Alkane 1 Monooxygenase)IBA 04/2024

Therapy/Procedure

23	Therapeutics 05/2024 - 09/2015
20	Drug Therapy (Chemotherapy) 05/2024 - 11/2014
8	Immunotherapy 05/2024 - 01/2021
2	Adjuvant Chemotherapy 12/2023 - 09/2023
2	Castration 01/2022 - 01/2016
2	Cryosurgery 11/2014 - 07/2013
1	Esophagectomy 05/2024